background. Temporal hair loss that results from traumatized hair follicles following rhytidectomy is an unsightly complication that can distress both the patient and the operating surgeon. Topical minoxidil is a proven therapy for androgenic alopecia and female senile alopecia. It has also been found to be useful in preventing the hair loss that commonly follows hair transplantation. objective. To analyze through a retrospective study the effect of topical minoxidil on the incidence of temporal hair loss following facelift procedures. To our knowledge this is the first study to investigate the role of minoxidil in preventing postrhytidectomy temporal alopecia. methods. The charts of 60 women with a mean age of 58 years who underwent primary cervicofacial rhytidectomy were studied. Either a standard SMAS/flap technique or pliation was done in all cases. Each patient received either 2% or 5% topical minoxidil for 2 weeks before surgery and for 4 weeks after surgery, with a 5-day break period beginning on the day of surgery. Patients were monitored for complications immediately postoperatively and in 3-6 months of follow-up.
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results. Almost 80% of the patients underwent SMAS/flap procedures. Transient temporal alopecia was noted in only one patient, 6 weeks after discontinuing minoxidil. This resolved within 4 weeks of its reintroduction. The only other complications noted included minor hematomas (3.3%), skin slough/infection (1.7%), minor transient and localized edema (8.3%), minor ecchymosis (1.7%), a unilateral neuropraxia of the buccal nerve lasting 3 months (1.7%), and a minor temporary unilateral skin depression (1.7%). Side effects of minoxidil were not observed. conclusion. On comparing our findings to results of larger rhytidectomy series in which minoxidil was not used prophylactically, and our experience before using minoxidil, we conclude that minoxidil plays a role in effectively preventing the temporal hair loss that occurs following primary cervicofacial rhytidectomies. We also found that minoxidil did not negatively impact on the risk of hematoma formation, skin necrosis, edema, or ecchymosis. Side effects of minoxidil did not present a problem.
PROCEDURES AIMED at reversing the appearance of the aging rhytides continue to gain in popularity for social, psychological, and even economic reasons. 1 These procedures and their innovations are considered cosmetic, thus more so than is the case with other elective surgical procedures, the amelioration or prevention of even relatively minor complications is paramount. 2 Temporal hair loss has long been recognized as a complication of rhytidectomy. Three causes of temporal hair loss after rhytidectomy have been recognized: [3] [4] [5] [6] temporal alopecia from compromised hair follicles which results from trauma; temporal alopecia resulting from posterior placement of temporal incisions which leads to the elevation of the temporal hair line; and alopecia that results from expanding scar on which hair cannot grow.
The focus of this review is hair loss resulting from traumatized follicles. This phenomenon has been attributed to a number of factors, including too superficial undermining of the temporal flap [6] [7] [8] [9] and excessive tension applied during mobilization of the temporal flap. [5] [6] [7] [8] [9] Patients with preoperative thinning of the temple hair appear to be more susceptible to the problem. 5, 7 This form of temporal alopecia is mostly a temporary event, but it can be permanent in some cases.
Although, literature is replete with discussions on the psychological impact of complications like hair loss after rhytidectomies, 6,10,11 there exists a relative scarcity of data on the incidence of hair loss (temporary versus permanent). In many instances, it is either not considered at all 12, 13 or is only given a cursory mention. 14, 15 Regardless of the cause, temporal alopecia has been the focus of various innovative surgical attempts at a remedy. 3, 4, 6, 10, 16 However, none of these proposed surgical techniques is without drawbacks, which can be either aesthetic or technical in nature. 3 Thus there con-tinues to be no substitute for adopting surgical techniques aimed at minimizing trauma to the temporal hair follicles. 5, 7, 9 Minoxidil is a piperidinopyrimidine derivative, and its topical form (active ingredient minoxidil sulfate) is the only topical medication that is approved by the U.S. Food and Drug Administration (FDA) for the treatment of androgenic alopecia. 17 It has also been found to be effective in the treatment of some forms of alopecia areata, 17 as well as in the prevention of the shedding of native hair adjacent to hair grafts after transplant. 18, 19 Although minoxidil is known for its vasodilatory properties, the mechanism by which it affects hair growth is unclear and appears to be unrelated to this property. 20, 21 Studies indicate that it increases DNA synthesis in follicular keratinocytes and perifollicular epithelium 22, 23 The pre-and postrhytidectomy use of topical minoxidil in the temporal and retroauricular hair has the potential for preventing the hair loss that results from follicular trauma (in a manner that is akin to the experience with minoxidil and hair shedding after hair transplantation 18, 19 ). Because of its vasodilatory properties, there is a potential for minoxidil to impact on the rate of hematoma formation, ecchymosis, skin necrosis, edema, and infections. Encouraged by the proven benefit of minoxidil in preventing hair loss after hair transplant, its proven effectiveness in female senile alopecia, and the beneficial trends observed by the senior author (S.E.) in his 3-4 years of experience with the anecdotal use of minoxidil on his rhytidectomy patients beginning from about 1990, he (S.E.) began using minoxidil on all his facelift patients. In this retrospective analysis, we studied the rate of temporal alopecia and other complications that followed the prophylactic use of 2% and 5% minoxidil in 60 cases of cervicofacial rhytidectomies performed at our clinic. The data are compared with the complication rates of previously reported rhytidectomy series in which minoxidil was not used. To our knowledge this is the first report to study the role of prophylactic use of topical minoxidil in rhytidectomies.
Materials and Methods
Through retrospective chart analysis, 60 consecutive cervicofacial rhytidectomy patients meeting the following criteria were selected for this study:
All female patients, since the author's technique for male facelifts did not involve much undermining of the temporal hair-bearing area. Primary rhytidectomy procedures only, since for secondary procedures, the senior author generally avoids high temporal scalp incisions and under-mining of that area to prevent significant elevation or distortion of the temporal and preauricular hair pattern. Patients over the age of 45 years with a minimum documented 3-month chart follow-up, since for younger patients the author avoids high temporal incisions as well.
All patients received a thorough preoperative evaluation, appropriate laboratory workup, informed consent, and preoperative photographs. All cases were performed under local anesthesia. Five percent (3 of 60 patients) received small doses of intravenous midazolam. All other patients received only oral and intramuscular sedation consisting of 0.25-0.5 mg triazolam or 2 mg lorazepam orally, and either butorphenol tartrate 2-4 mg or meperidine 75-100 mg given along with diphenhydramine 50-75 mg all intramuscularly. Local anesthesia utilized a superwet hydrodissection technique by infiltration with a spinal needle of 300-400 cc of 0.15-0.20% xylocaine with epinephrine 1: 150,000-1:200,000.
The operating surgeon (S.E.) has performed facelifts since 1984. For patients more than 45 years of age undergoing primary facelift procedures, the technique generally involved wide undermining of the temporal hair-bearing area extending over the lateral aspect of the temporal forehead, and continued medially and inferiorly over the zygomatic area and lateral zygoma to the lateral portion of the orbital rim. A thick skin flap was always maintained, with skin flap elevation limited medially by an imaginary line from the lateral canthus to a point 1 cm lateral to the corner of the mouth. Depending on need, SMAS/platysma flaps were used in approximately two-thirds of the patients and plication of the SMAS in about one-third of patients.
The direction of pull/vectors were marked on the skin prior to surgery based on findings. The direction of the SMAS flap, which was frequently divided at the level of the ear lobe, was generally more superior than the lower SMAS/platysma portion of the flap which was more directly posterior. The skin flap which was generally long, and as thick as possible, and well separated at the supra-SMAS level, was usually advanced in a more directly posterior position (versus the more superior vector of the upper SMAS flap) to avoid elevation and distortion of the hairline.
A secondary incision and triangular skin resection was carried out at the superior level of the tragus when necessary, again to avoid hair pattern distortion. 4 Suction lipectomy was performed as necessary in the jowl or neck area, generally in a conservative fashion, avoiding excessive thinning of the skin flap. 5 Platysmal work was performed as needed, including division and resection of platysmal bands, fol-lowed by corset-type midline imbrication of the platysma and direct defating of the supra-and subplatysmal plane as dictated by individual needs, through a submental incision with the use of fiberoptic retractors. 5 The earlobe was occasionally modified to create one. Other aspects of the surgical techniques were relatively constant and are summarized below.
The incisions were marked with a retrotragal anterior auticular incision, a high postauricular incision 1 cm anterior to the retroauricular crease posterior to the retroauricular ligament, always with a V-type notch over the mastoid area and into the inferior hairline. The posterior length of the incision generally varied depending on the extent of the neck flap elevation. In the area of hair-bearing skin incisions, the scalpel blade was always angled. After the elevation of the skin flap, completion of the SMAS and platysma was done with meticulous attention to hemostasis. The skin flap was redraped with pre-and postauricular fixation points. The skin flap was trimmed with a ret-rotragal flap and sutured with 5-0 nylon with essentially no tension in the pre-and postauricular aspects of the closure. Mild and moderate tension was placed on the temporal aspect of the skin flap. Moderate tension was placed on the posterior skin flap closure. The posterior flap was rotated as anteriorly as possible to avoid hairline stepoff.
The hair-bearing skin was closed with small steel staples and non-hair-bearing skin with 5-0 nylon. For SMAS and platysma, 2-0 or 3-0 PDS was used. Bilateral Penrose drains were placed in virtually all patients and removed in 24-48 hours. Fluffy dressings were used, supported by a light netting or garment. All patients received prophylactic antibiotics starting 24 hours preoperatively and continued for 5-7 days postoperatively. Cefadroxil 1 g/day, cephalexin 500 mg four times a day, or ciprofloxacin 500 mg twice a day were used. Minoxidil 2-5% was started 1 week preoperatively, and continuing after a 5-day break period postoperatively for another 4 weeks. Pre-and 
Results
Sixty women between the ages of 45 and 85 years (mean 58 years) underwent 60 primary cervicofacial rhytidectomies. Forty-six of the 60 procedures involved harnessing SMAS flaps, while in the remaining 14 the SMAS were plicated. In 49 patients, a platysmaplasty was necessary. Minoxidil 5% was used prophylactically in 30 rhytidectomies, while in the remaining 30, 2% minoxidil was used. Eleven (18%) patients had a history of cigarette smoking; 9 patients had a history of medically controlled hypertension. A patient who smoked also had a history of peripheral vascular disease for which she was on pentoxifylline. Table 1 summarizes the demographic data of our patients. In 42 of 60 patients, one or more ancillary cosmetic procedures were done concomitantly. These are shown in Table 2 .
Complications
Large hematomas requiring surgical evacuation or aspiration were not observed in any patient. Two small hematomas that occurred within 1 week of rhytidectomy were noted. These resolved spontaneously without any sequelae. One of these patients had a history of controlled hypertension. One patient experienced left temporal alopecia 10 weeks postoperatively. She was resumed on 5% topical minoxidil, following which the alopecia resolved within 10 weeks of treatment. No history of temporal hair thinning was noted in this patient prior to rhytidectomy. One patient had neuropraxia of the buccal branch of the left facial nerve, resulting in the patient having difficulties in sucking on a straw for the 3 months it took for the problem to resolve spontaneously. One patient had a preauricular purulent collection that grew Staphylococcus epidermisis on culture. The area was debrided. subsequently a 2 cm ϫ 2 cm area of necrosis developed at the site. The patient who had received a prophylactic course of cephalexin is an active smoker who continued to smoke postoperatively, she also had a history of hypertension. Healing occurred in this case without untoward cosmetic sequelae. Minor superficial skin necroses (less than 0.5 cm) were observed in three patients, and in all three cases, healing occurred with a good cosmetic outcome. One patient had a small depression at the left nasolabial area that was corrected with an injection of 5 cc or autologous fat 12 weeks after her rhytidectomy. Two patients who underwent concomitant CO 2 laser resurfacing procedures, experienced herpetic eruptions in the perioral area within 2 and 6 weeks of rhytidectomy upon termination of their prophylactic regimen of famciclovir. The lesions healed uneventfully on resumption of famciclovir at a therapeutic regimen. One patient had minor ecchymosis affecting less than 2.0 cm, and minor edemas involving less than a 3 cm area were observed in 5 (8.3%) patients. Ecchymosis and edema resolved rather quickly without untoward sequelae. None of the patients had any anesthetic complications, hypertrophic or unsightly scarring, aspiratable seroma, dyschromia, telangiectasias, or overall dissatisfaction with the procedure. Table 3 summarizes all complications observed in this review. None of the patients developed hypotension, hirsuitism, local irritation, or contact allergy, which are known side effects of topical minoxidil. 17
Discussion
Because topical minoxidil is known to reverse or slow down hair loss, as well as its known direct vasodila- tory properties, the aspects of rhytidectomies where it may potentially have some impact include temporal alopecia that results from traumatized hair follicles, hematoma, ecchymosis formation, edema, skin necrosis, as well as infection rate.
Hair Loss
Despite the consistency with which texts list temporal alopecia that results from follicular injury as a complication of rhytidectomy, there exist scarce data on its incidence in the various studies cited in the literature. Where this is reported, details tend to be vague regarding the proportion of alopecia that is temporary or permanent. 11 It is curious to note that the only case of temporary hair loss we observed occurred 10 weeks postoperatively, some 6 weeks after stopping her minoxidil prophylactic therapy. This falls within the range of time it takes to begin to loose the protective effect minoxidil has on hair follicles. This observation suggests that minoxidil did play a protective role, which was lost 6 weeks after cessation of therapy, resulting in hair loss. This patient grew back her hair within 2 months of restarting minoxidil therapy. A 1-3% incidence of alopecia requiring surgical revision (permanent) after rhytidectomy has been reported. 24 Table 4 summarized the scant data on hair loss incidence from previous rhytidectomy series reports. Of the 8.4% alopecia rate reported by Leist et al., 11 no clear delineation was made between temporary and permanent alopecia. Many rhytidectomy reports simply did not mention their finding with regards to the incidence of temporal alopecia. 12, 13 Our findings of 0% incidence of permanent alopecia and 1.7% of temporary alopecia in patients using minoxidil prophylactically is encouraging when compared with the data found in previous reports, albeit scant. We compare these findings with the observations of the senior author showing permanent and temporary temporal alopecia in 2-3% and 5-8%, respectively, of his rhytidectomy patients prior to the use of minoxidil. This observation of significant hair loss prior to the use of minoxidil was made despite the utilization of the same surgical techniques elucidated earlier. Macgregor 7 has classified hair loss as a major complication of rhytidectomies, while both Rees and Ashton 5 and Baker et al. 24 classified the phenomenon as minor. Regardless of how it is classified, the bald appearance of the temporal area after rhytidectomy and the unsightly appearance of the scar it exposes is a veritable source of psychological distress for both the patients and surgeons involved. This leads to a frustrating sense of deformity in the patient which translates to overall dissatisfaction with the outcome of the procedure no matter how well the rhytides turn out. 10 Many surgical remedies have been proposed to treat temporal alopecia after rhytidectomies. 3, 4, 6, 10, 15 How- ever, none has been found to be altogether satisfactory, either because of poor aesthetic outcome and/or technical challenges presented by the procedure. 3 Clearly measures should be aimed at preventing the problem, such as undermining the temporal skin flap to a depth that avoids the hair follicles and minimizing tension during flap closure, and in patients whose hair is already thinning prior to surgery, incisions should be located anterior to the hair margins. The concept of using topical minoxidil for the prevention of postrhytidectomy temporal alopecia secondary to follicular embarrassment is a novel one, having not been reported previously. However, an analogy could be drawn from the experience with hair transplant surgery, where topical minoxidil was shown to effectively prevent the shedding of native hair located adjacent to the grafted hair. 18, 19 Our data support that topical minoxidil prevents permanent temporal alopecia caused by damage to the hair follicles in patients undergoing rhytidectomies.
Hematoma
Hematoma is the most common complication in rhytidectomy, 5, 7, [24] [25] [26] [27] and expanding hematoma the most feared. 28, 29 Despite the vasodilatory property of minoxidil, no case of expanding hematoma was observed in any of our patients. Even after lowering the threshold for calling hematoma (less than 2 cc hematoma that resolved without requiring aspiration), only 2 cases (3.3%) were noted. We deduced from our findings that prophylactic topical minoxidil did not predispose to a higher rate of hematoma, since our hematoma rate compares favorably with findings in bigger studies that reported on the incidence of both major and minor hematoma ( Table 5 ). In past analyses of several rhytidectomy series, the overall incidence of minor hematomas was reported as 15%, 1,24 while expanding hematomas was placed at 3.5%. 25 A review of rhytidectomy series over the years indicates that there has been a decreasing trend in hematoma rates over the years. This has been attributed to the use of retractors that incorporate fiberoptic lights. 26 Several factors that were once thought to influence hematoma rates, such as general versus local anesthesia, pre-, intra-, or postoperative hypertension, nausea and vomiting, and type of surgery, have either been disproved or still remain controversial due to conflicting reports. Clearly patients with bleeding diastasis either secondary to disease or medications are at a greater risk. Men have been shown to have a higher incidence of hematoma due to some unique anatomic factors. 8
Sloughing and Infection
Both skin sloughing and wound infections are infrequent complications of rhytidectomies. A single patient in our report developed a 2 cm ϫ 2 cm area of purulence in the preauricular area, 4 days postoperatively. She did not have fevers and had received an 11day course of antibiotics (cephalexin) beginning 24 hours before surgery. Cultures grew S. epidermidis , which may well be a contaminant. When debrided, no retained sutures were retrieved. The area later exhibited some superficial sloughing involving an area measuring 2 cm ϫ 2 cm. She was given a 7-day course of ciprofloxacin. The area healed quite well, with very good cosmetic results. Of note in this patient are a number of factors unrelated to her use of minoxidil which may account for this observation: the patient is hypertensive and an active smoker who continued to smoke postoperatively. Rees et al. 30 report a higher incidence of skin necrosis in smokers (7.5%) compared to nonsmokers (2.5%) who underwent rhytidectomies. This finding was buttressed by Sullivan et al., 2 who found an incidence of 12.5% and 2.5% for smokers and nonsmokers, respectively. Going by the classification for skin sloughs after rhytidectomy, 14, 24 this case can be categorized as moderate (greater than 0.5 cm and less than 2.5 cm). Our finding of a single case of "moderate" skin slough and the absence (0%) of major skin necrosis compares favorably to the incidence of "major" skin sloughs in previous rhytidectomy series reports (Table 6 ). In rhytidectomies, skin necrosis occurs most commonly in the mastoid area due to the relative poor blood supply to that region. Factors that contribute to necrosis include increased tension placed on skin flaps, 5, 7 underlying hematoma regardless of size, since hematomas have been determined to release factors that induce ischemia in the overlying skin flap, 31 smoking, 2,30 excessive trauma, tension, and pressure exerted by instruments such as clamps, forceps, skin hooks, and retractors, 5 excessive undermining, and underlying infection. 5 Most skin sloughs in rhytidectomies are superficial and minor (less than 0.5 cm 14 ). Skin sloughs measuring more than 2.5 cm are considered major. 24 Three (5%) of our patients, none of whom smoked, had minor superficial skin sloughs, all of which required no intervention and healed well with good cosmesis. An incidence of 5% of minor skin necrosis compares favorably against the scant data available in previous reports (Osguthorpe and Lomax, 14 10.5%; Thompson and Ashley, 12 12%).
The primary mechanism by which skin necrosis occurs is believed to be initiated by venous congestion. 5 Since vasodilation can potentially impact on this process, it becomes pertinent to document the influence of minoxidil, a known vasodilator, on skin flap necrosis when considering its prophylactic use in rhytidectomies. Our data do not show any significant effect on the incidence of all forms of skin necrosis with the use of topical minoxidil.
Fortunately, serious wound infections remain rare in rhytidectomies. In an analysis of rhytidectomy reports involving 6166 patients, Leroy et al. 32 found only a 0.18% incidence of wound infections that required hospital admissions. The problem with wound infection reports is the paucity of information as to what constitutes a significant wound infection. In our single patient in whom we observed purulence, and in whom the only case of moderate skin loss was documented, it is unclear if she should be categorized as having a wound infection. S. epidermidis, which grew from the wound, is a common skin contaminant, being part of the normal skin flora. It hardly plays an active role in immunocompetent patients. Previous reports indicate that the usual suspects in rhytidectomy wound infections are Staphylococcus aureus and Streptococcus species. 24, 32 The pu-rulence noted in our patient could have been sterile, and may have resulted from tissue necrosis and inflammation mediated by her active cigarette smoking. However, even if this were to be counted a wound infection, our data compare favorably with previous reports ( Table 7 ).
The rarity of wound infections after rhytidectomy has been attributed to the relatively rich blood supply to the face, scalp, and upper neck region. 24, 25, 32, 33 Topical minoxidil, by virtue of its vasodilatory properties, could potentially play an advantageous role, however, it constitutes a foreign substance that is applied to a surgical area, hence the potential for introducing organisms. Our data do not support that prophylactic use of topical minoxidil plays any role in the rate of wound infection in rhytidectomies.
Ecchymosis, Pigmentary Changes, and Edema
The concern about the possible potential for an increase in the rate of ecchymosis and it's dyschromic sequelae 7, 25 which may be expressed regarding the effect of a vasodilator such as minoxidil in rhytidectomy areas was not borne out by our data, which showed only one incidence of noticeable ecchymosis in the preauricular area. This was minor, measuring about 2 cm in diameter, and resolving within 3 weeks with no dyschromia or other untoward sequelae.
Postrhytidectomy edema is said to be very common, and is usually localized and very temporary. It mostly results from rough handling of tissues and venous stasis. 7, 25 Minoxidil as a vasodilator could theoretically promote edema by increasing vascular permeability. On the other hand, it may reduce edema by reducing hydrostatic pressure. Five (8.3%) of our patients developed mild to moderate edema involving small areas of the operative field. This is usually very localized, cosmetically insignificant, and resolves quite quickly, usually within a few days.
Steroids were not used in any of the reported cases of ecchymosis or edema because they were cosmetically insignificant, and studies have not shown steroids to be beneficial either before or after rhytidectomy. 34, 35 Unfortunately we could find no data in the literature with which to compare our numbers on the rate of edema and ecchymosis.
Hirsuitism, Irritation, Contact allergy, and Hypertension
Known side effects of topical minoxidil include hirsuitism, irritation (dryness, itching, erythema) secondary to the additive propylene glycol, and allergic contact dermatitis. 17 There also exists a potential for hypotension. None of these side effects were reported by any of our patients. All the stated side effects are entirely reversible upon cessation of further therapy. 17 Further, the use of minoxidil in rhytidectomies is short term and not likely to cause genuine concerns for hirsuitism as a problem.
In the future a much larger study will be required to better stratify and determine the optimal period for the prophylactic use of topical minoxidil before and after rhytidectomy. Our experience with the one case of temporal alopecia may suggest a benefit from using minoxidil for at least 2-3 months postoperatively. Perhaps a cue could be taken from studies on the use of topical minoxidil in the prevention of the hair shedding that occurs after hair transplantation in which minoxidil is used for 4 weeks pretransplant and continued (after a 1-week break postsurgery) for another 3 months after hair transplantation. 22 In conclusion, our findings support that a role exists for topical minoxidil (2% or 5%) in the amelioration of the temporal alopecia that results from follicular embarrassment following cervicofacial rhytidectomies. Our data also show that concerns for its theoretical potential to impact on complications such as hematoma, skin loss, infection rate, edema, and ecchymosis are unfounded. Side effects of hirsuitism, irritation, and contact allergy did not present a challenge.
Neuropraxia
Neuropraxia of the buccal branch of the right facial nerve occurred in one of our patients who underwent SMAS/flap rhytidectomy. The patient experienced difficulties in performing tasks like puckering of the lips or drawing on a straw for the 3 months it took for the problem to resolve without intervention. McGregor 7 found that the buccal nerve was the most common nerve to be damaged following facelifts. Other series 25, 26 have cited either the temporal or mandibular branches to be most commonly affected. Neuropraxia is usually a temporary problem, and commonly resolves within 3-6 months of surgery. Common causes include inadvertent clamping, electrocoagulation, and stretching during harnessing of SMAS flap. We found no reason to believe that the use of minoxidil is connected to this complication.
